Cabot (NYSE:CBT – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.000-6.500 for the period, compared to the consensus EPS estimate of 6.530. The company issued revenue guidance of -.
Cabot Price Performance
Shares of CBT traded down $1.72 during trading hours on Tuesday, reaching $71.14. 718,037 shares of the stock traded hands, compared to its average volume of 438,937. The company has a market cap of $3.76 billion, a P/E ratio of 11.84, a price-to-earnings-growth ratio of 3.82 and a beta of 0.88. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $68.50 and its two-hundred day moving average price is $71.61. Cabot has a 52-week low of $58.33 and a 52-week high of $89.16.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The business had revenue of $849.00 million for the quarter, compared to analysts’ expectations of $889.11 million. During the same period last year, the firm earned $1.76 earnings per share. The business’s quarterly revenue was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, analysts anticipate that Cabot will post 7.57 earnings per share for the current year.
Cabot Dividend Announcement
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Mizuho upped their price target on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Jefferies Financial Group restated a “buy” rating and set a $81.00 target price on shares of Cabot in a research report on Thursday, January 8th. JPMorgan Chase & Co. reduced their price target on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. Finally, UBS Group boosted their price target on shares of Cabot from $65.00 to $74.00 and gave the stock a “neutral” rating in a research note on Monday, January 12th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $72.25.
View Our Latest Analysis on Cabot
Key Headlines Impacting Cabot
Here are the key news stories impacting Cabot this week:
- Positive Sentiment: Adjusted EPS beat consensus (Adjusted EPS $1.53 vs. Zacks estimate $1.40), which supports underlying profitability despite a tougher demand backdrop. Read More.
- Positive Sentiment: Signed a multi‑year supply agreement with PowerCo SE to supply conductive carbons for lithium‑ion batteries — a strategic win that supports growth in the higher‑margin Battery Materials business. Read More.
- Positive Sentiment: Strong cash generation (operating cash flow $126M) funded $76M returned to shareholders (share repurchases + $24M dividends), supporting capital return policy and near‑term shareholder support. Read More.
- Positive Sentiment: Board declared a quarterly dividend of $0.45 per share (payable Mar 13; ex‑div Feb 27), providing income support for dividend investors. Read More.
- Positive Sentiment: Completed acquisition of Mexico Carbon Manufacturing (MXCB) from Bridgestone — expands manufacturing footprint and vertical integration in carbon products. Read More.
- Neutral Sentiment: Company narrowed full‑year Adjusted EPS guidance to $6.00–$6.50, reflecting negotiated tire customer outcomes and the current demand outlook — gives investors updated framework but contains downside risk if volumes stay weak. Read More.
- Negative Sentiment: Revenue missed expectations: Q1 sales $849M (-11% YoY) vs. consensus ~ $889–$896M; gross profit and operating profit fell year‑over‑year — the top‑line miss is the main driver of the intraday selloff. Read More.
- Negative Sentiment: Reinforcement Materials EBIT declined 22% YoY (global volumes down ~7%, Americas down ~15%) as tire customer production and inventory dynamics pressured volumes — this is a material segment weakness that clouds near‑term growth. Read More.
- Negative Sentiment: Notable insider selling (CEO sales disclosed) in recent months may concern some investors about near‑term confidence. Read More.
Hedge Funds Weigh In On Cabot
A number of institutional investors and hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC increased its holdings in shares of Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after buying an additional 478,702 shares during the last quarter. UBS Group AG grew its position in Cabot by 186.7% in the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after acquiring an additional 386,514 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after acquiring an additional 108,645 shares during the last quarter. Barclays PLC raised its position in Cabot by 60.6% during the third quarter. Barclays PLC now owns 267,989 shares of the specialty chemicals company’s stock valued at $20,381,000 after purchasing an additional 101,168 shares during the period. Finally, Man Group plc raised its position in Cabot by 28.2% during the second quarter. Man Group plc now owns 340,823 shares of the specialty chemicals company’s stock valued at $25,562,000 after purchasing an additional 74,918 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
